Wellington Management Group
NKTR icon

Wellington Management Group’s Nektar Therapeutics NKTR Stock Holding History

Wellington Management Group’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$802K Buy
+11,488
New +$841K ﹤0.01% 1782
2025
Q1 		– Sell
-34,827
Closed -$486K – 2015
2024
Q4 		$486K Buy
34,827
+3,288
+10% +$58K ﹤0.01% 1837
2024
Q3 		$615K Buy
+31,539
New +$601K ﹤0.01% 1792
2022
Q4 		– Sell
-758,915
Closed -$36.4M – 2073
2022
Q3 		$36.4M Hold
758,915
– – 0.01% 743
2022
Q2 		$43.3M Hold
758,915
– – 0.01% 721
2022
Q1 		$61.4M Hold
758,915
– – 0.01% 694
2021
Q4 		$154M Hold
758,915
– – 0.02% 514
2021
Q3 		$204M Hold
758,915
– – 0.03% 432
2021
Q2 		$195M Hold
758,915
– – 0.03% 446
2021
Q1 		$228M Sell
758,915
-133,926
-15% -$41.7M 0.04% 398
2020
Q4 		$228M Sell
892,841
-117,349
-12% -$30.3M 0.04% 381
2020
Q3 		$251M Buy
1,010,190
+91
+0% +$28.6K 0.05% 312
2020
Q2 		$351M Sell
1,010,099
-39,698
-4% -$12.4M 0.08% 222
2020
Q1 		$281M Sell
1,049,797
-28,508
-3% -$8.82M 0.07% 235
2019
Q4 		$349M Sell
1,078,305
-21,758
-2% -$6.31M 0.07% 270
2019
Q3 		$301M Buy
1,100,063
+234,710
+27% +$86.1M 0.07% 277
2019
Q2 		$462M Buy
865,353
+1,249
+0.1% +$626K 0.1% 216
2019
Q1 		$436M Buy
864,104
+148,013
+21% +$87.7M 0.1% 216
2018
Q4 		$353M Buy
716,091
+202,550
+39% +$122M 0.09% 238
2018
Q3 		$470M Buy
513,541
+58,925
+13% +$50.3M 0.1% 221
2018
Q2 		$333M Buy
454,616
+222,972
+96% +$257M 0.07% 273
2018
Q1 		$369M Buy
231,644
+96,833
+72% +$125M 0.08% 249
2017
Q4 		$121M Buy
+134,811
New +$79.7M 0.03% 502
2015
Q1 		– Sell
-10,111
Closed -$2.35M – 2212
2014
Q4 		$2.35M Sell
10,111
-151
-1% -$32.3K ﹤0.01% 1651
2014
Q3 		$1.86M Buy
10,262
+2,680
+35% +$513K ﹤0.01% 1694
2014
Q2 		$1.46M Buy
7,582
+369
+5% +$65.3K ﹤0.01% 1742
2014
Q1 		$1.31M Buy
+7,213
New +$1.43M ﹤0.01% 1773

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group's NKTR Position: Q2 2026 in Review

Wellington Management Group opened a new position in Nektar Therapeutics (NKTR) in Q2 2026: 11,488 shares worth $802K. The stake represents ﹤0.01% of the portfolio and ranks #1782 among its holdings. This is a return to the name: Wellington Management Group previously reported a position in NKTR as recently as Q4 2024.

Wellington Management Group first reported a position in NKTR in Q1 2014 and has held it in 27 quarters since. The position peaked at $470M in Q3 2018. 239 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • Wellington Management Group held 11,488 shares of Nektar Therapeutics worth $802K as of Q2 2026.
  • Nektar Therapeutics was a new Wellington Management Group position in Q2 2026.
  • Nektar Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1782 holding.
  • Wellington Management Group first reported a position in Nektar Therapeutics in Q1 2014 and has held it in 27 quarters since.
  • Wellington Management Group's Nektar Therapeutics position peaked at $470M in Q3 2018.
  • 239 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.